ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
A letter questions whether AI is genuinely helpful for drug discovery. The author examines the gap between AI's promise and its practical impact on developing new medicines. The piece highlights ongoing skepticism about AI's effectiveness in pharmaceutical research and development.
Tap to vote and see what everyone thinks.
Summary by ByteBrief